UA116626U - METHOD OF CORRECTION OF METABOLIC DISORDERS IN ANIMALS UNDER CONDITIONS OF COMBINED EXPOSURE OF TETRACHLORMETHANE AND CARBOPHOSE - Google Patents

METHOD OF CORRECTION OF METABOLIC DISORDERS IN ANIMALS UNDER CONDITIONS OF COMBINED EXPOSURE OF TETRACHLORMETHANE AND CARBOPHOSE

Info

Publication number
UA116626U
UA116626U UAU201613230U UAU201613230U UA116626U UA 116626 U UA116626 U UA 116626U UA U201613230 U UAU201613230 U UA U201613230U UA U201613230 U UAU201613230 U UA U201613230U UA 116626 U UA116626 U UA 116626U
Authority
UA
Ukraine
Prior art keywords
correction
under conditions
metabolic disorders
carbophose
tetrachlormethane
Prior art date
Application number
UAU201613230U
Other languages
Ukrainian (uk)
Inventor
Лариса Анатоліївна Бойко
Людмила Степанівна Фіра
Петро Григорович Лихацький
Наталя Іванівна Бурмас
Original Assignee
Державний Вищий Навчальний Заклад "Тернопільський Державний Медичний Університет Імені І.Я. Горбачевського Моз України"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Державний Вищий Навчальний Заклад "Тернопільський Державний Медичний Університет Імені І.Я. Горбачевського Моз України" filed Critical Державний Вищий Навчальний Заклад "Тернопільський Державний Медичний Університет Імені І.Я. Горбачевського Моз України"
Priority to UAU201613230U priority Critical patent/UA116626U/en
Publication of UA116626U publication Critical patent/UA116626U/en

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Спосіб корекції метаболічних порушень в організмі тварин за умов комбінованого впливу тетрахлорметану та карбофосу. Застосовують препарат мексидол у дозі 16 мг/кг маси тіла.Method for correction of metabolic disorders in animals under conditions of combined exposure to carbon tetrachloride and carbophos. Use the drug Mexidol at a dose of 16 mg / kg body weight.

UAU201613230U 2016-12-23 2016-12-23 METHOD OF CORRECTION OF METABOLIC DISORDERS IN ANIMALS UNDER CONDITIONS OF COMBINED EXPOSURE OF TETRACHLORMETHANE AND CARBOPHOSE UA116626U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201613230U UA116626U (en) 2016-12-23 2016-12-23 METHOD OF CORRECTION OF METABOLIC DISORDERS IN ANIMALS UNDER CONDITIONS OF COMBINED EXPOSURE OF TETRACHLORMETHANE AND CARBOPHOSE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201613230U UA116626U (en) 2016-12-23 2016-12-23 METHOD OF CORRECTION OF METABOLIC DISORDERS IN ANIMALS UNDER CONDITIONS OF COMBINED EXPOSURE OF TETRACHLORMETHANE AND CARBOPHOSE

Publications (1)

Publication Number Publication Date
UA116626U true UA116626U (en) 2017-05-25

Family

ID=74214137

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201613230U UA116626U (en) 2016-12-23 2016-12-23 METHOD OF CORRECTION OF METABOLIC DISORDERS IN ANIMALS UNDER CONDITIONS OF COMBINED EXPOSURE OF TETRACHLORMETHANE AND CARBOPHOSE

Country Status (1)

Country Link
UA (1) UA116626U (en)

Similar Documents

Publication Publication Date Title
CL2017001117A1 (en) Methods to treat eye diseases.
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
MX2021000538A (en) Sobetirome in the treatment of myelination diseases.
MX2017010982A (en) Use of pridopidine to improve cognitive function and for treating alzheimer's disease.
PH12015501531B1 (en) Crenolanib for treating flt3 mutated proliferative disorders
PH12017500163A1 (en) Optionally fused heterocyclyl - substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
PH12017502379A1 (en) Drospirenone-based contraceptive for a female patient affected with excess weight
MX2018005756A (en) Targeting of the formyl-peptide receptor 2/lipoxin a4 receptor (fpr2/alx) for treatment of heart disease.
EA201691656A2 (en) THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS
TR201908151T4 (en) Isoindoline derivatives.
UA116626U (en) METHOD OF CORRECTION OF METABOLIC DISORDERS IN ANIMALS UNDER CONDITIONS OF COMBINED EXPOSURE OF TETRACHLORMETHANE AND CARBOPHOSE
UA125971U (en) METHOD OF STRENGTHENING ANTI-INFLAMMATORY ACTION OF Meloxicam
AR102494A1 (en) METHODS TO TREAT EYE DISEASES
MX2016010104A (en) Use of paricalcitol in the treatment of inflammatory anaemia.
UA103300U (en) The use of chondroitin sulfate correcting cytostatics induced by disruption of spermatogenesis in experiment
EA201992284A1 (en) COMPOSITIONS AND METHODS FOR TREATING SINUCLEINOPATHIES
PH12016502113A1 (en) Drug for treatment of tinnitus patients
UA105657U (en) Method for modeling toxic hepatitis
UA124910U (en) METHOD OF TREATMENT OF COGNITIVE DISORDERS IN DISCIRCULATORY ENCEPHALOPATHY IN POSTMENOPAUSE
IN2014DE00818A (en)
PH12014000105A1 (en) Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds
UA113415U (en) METHOD FOR CORRECTION OF MELATONINE MORPHOLOGICAL DISORDERS
MD4458B1 (en) Use of Polybiolin drug in patients with liver cirrhosis
UA114780U (en) METHOD OF CORRECTION OF ENDOTHETAL DYSFUNCTION IN PATIENTS WITH AUTOMIMUNE THYROIDITIS IN THE PRESENCE OF ATEROSCLEROTIC VASUAL DAMAGE
UA75277U (en) Method for treating dystrophic diseases of retina and choroid